Raman Spectroscopy for Cancer Diagnosis - - Spectroscopy
 Home   Mass Spectrometry   ICP-MS   Infrared   FT-IR   UV-Vis   Raman   NMR   X-Ray   Fluorescence  
Home
Magazine
Issue Archive
Subscribe/Renew
Special Issues
Reprints
The Application Notebook
Current Issue
Archive
Submission Guidelines
Training
SpecAcademy
E-solutions
Digital Edition
Subscribe to the Digital Edition
The Wavelength
Subcribe to The Wavelength
Subscribe to the MS E-news
Resources
Market Profiles
Information for Authors
SpecTube
Webcasts
Advertiser services
Contact Us
Columns
Atomic Perspectives
Chemometrics in Spectroscopy
Focus on Quality
Laser and Optics Interface
Mass Spectrometry Forum
The Baseline
Molecular Spectroscopy Workbench

Raman Spectroscopy for Cancer Diagnosis


Spectroscopy
Volume 21, Issue 11, pp. 33-41

Raman spectroscopy is a promising new tool for noninvasive, real-time diagnosis of tissue abnormalities. Here, we show evidence of its application for cancer diagnosis in four distinct tissue types: skin, breast, gastrointestinal tract, and cervix. Multivariate statistical analysis and discrimination algorithms allow for automated classification of the spectra into clinically relevant pathological categories using histology as a gold standard. Although limitations exist, the technique shows every indication of being an exciting prospect in the management of cancer in a clinical setting.

Optical spectroscopy has been around for many years and traditionally has been applied to a number of diverse fields, including analytical chemistry, geology, and even art history. Over the past 20–25 years, the use of optical spectroscopy for biomedical applications has grown significantly. Its attractiveness comes from its ability to provide quantitative information about the biochemical and morphological states of tissue in a minimally invasive or noninvasive manner. Spectra typically are collected with fiber-optic probes and charge-coupled device (CCD) cameras, and diagnostic algorithms have been developed to discriminate between different categories of tissue. Of the many optical spectroscopic techniques, fluorescence spectroscopy was one of the first to be developed as a diagnostic tool for a variety of diseases including cancers and plaques, as well as other conditions such as burns. However, although fluorescence spectroscopy can differentiate between normal tissue and disease (cancer) successfully, it suffers from a lack of specificity when differentiating between multiple nonnormal groups. Diffuse reflectance spectroscopy provides valuable structural information by determining tissue optical properties. The lack of information regarding tissue biochemistry makes this method generally insufficient by itself for tissue diagnosis. In recent years, Raman spectroscopy has garnered a great deal of interest in disease diagnosis, particularly cancer, because of its ability to provide molecular specific information about tissues.

Raman Spectroscopy

Raman scattering is an inelastic scattering process that occurs when an electron enters a virtual excited state due to an incident photon, then falls back to a higher or lower vibrational energy level with accompanying release of a new photon. The energy transfer is proportional to a specific vibrational mode of the molecule, so Raman spectra are independent of excitation wavelength, and the change in energy between the incident and released photon is displayed as relative wavenumbers (1/wavelength). Raman spectral peaks tend to be narrow, particularly in the fingerprint region of about 700–2000 cm–1 , and each peak can be associated with specific vibrations in molecular bonds. Thus, this technique provides biochemical information about a sample, including conformations and concentrations of constituents with the level of detail that is determined by the instrumentation and the need of the application (1).

Over the years, different forms of Raman spectroscopy have been developed and used for biological applications. The earliest of these is Fourier transform (FT)–Raman spectroscopy, a method that measures Raman spectra with high signal-to-noise ratio (S/N) and minimal fluorescence interference and has been used for many in vitro applications. The typically long integration times and bulky instrumentation negate this technique for in vivo use. Ultraviolet resonance Raman (UVRR) spectroscopy can be used to target specific molecules by selecting excitation wavelength at their resonance, thus yielding strong Raman signals. The high excitation intensities and mutagenicity of UV light prevent the application of this technique for in vivo use. Surface-enhanced Raman spectroscopy (SERS) is an excellent technique that can detect molecular signatures in trace amounts and has been pursued for such applications as biochips. However, the use of silver and other such elements for enhancement prevents its implementation in vivo. Thus, near-infrared (NIR) dispersive Raman spectroscopy, in which NIR excitation minimizes fluorescence and absorption by tissue, has been the technique of choice for in vivo applications (1).


Rate This Article
Your original vote has been tallied and is included in the ratings results.
View our top pages
Average rating for this page is: 4.67
Headlines from LCGC North America and Chromatography Online
Electronic Control of Carrier Gas Pressure, Flow, and Velocity
Application of Pyrolysis–Gas Chromatography–Mass Spectrometry for the Identification of Polymeric Materials
When Bad Things Happen to Good Food: Applications of HPLC to Detect Food Adulteration
The Column — NOW global!
Editors' Series: Gas Chromatography – Vacuum Ultraviolet Spectroscopy: A New and Worthy Alternative
Source: Spectroscopy,
Click here